Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene M Shearer

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
F1000 Medicine Reports|August 31, 2011
Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategyGene M Shearer, Adriano Boasso
Current Drug Metabolism|April 14, 2007
How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulationAdriano Boasso, Gene M Shearer
Clinical Immunology (Orlando, Fla.)|October 6, 2007
Chronic innate immune activation as a cause of HIV-1 immunopathogenesisAdriano Boasso, Gene M Shearer
AIDS Reviews|June 2, 2006
Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?Jean-Philippe Herbeuval, Gene M Shearer
AIDS Research and Human Retroviruses|August 7, 2007
Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshopClaire A Chougnet, Gene M Shearer
Autoimmunity|December 17, 2009
Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupusCharles S Via, Gene M Shearer
Clinical Immunology (Orlando, Fla.)|November 23, 2006
HIV-1 immunopathogenesis: how good interferon turns badJean-Philippe Herbeuval, Gene M Shearer
Current Infectious Disease Reports|May 23, 2002
The Role of Antigen-presenting Cells in HIV PathogenesisClaire Chougnet, Gene M. Shearer, Alan L. Landay
Neuroscience Letters|May 7, 2008
Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cellsOscar D Cano, Gabriele Neurauter, Dietmar Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2007
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alphaAndrew W Hardy, David R Graham, Gene M Shearer, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
F1000 Medicine Reports|August 31, 2011
Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategyGene M Shearer, Adriano Boasso
Current Drug Metabolism|April 14, 2007
How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulationAdriano Boasso, Gene M Shearer
Clinical Immunology (Orlando, Fla.)|October 6, 2007
Chronic innate immune activation as a cause of HIV-1 immunopathogenesisAdriano Boasso, Gene M Shearer
AIDS Reviews|June 2, 2006
Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?Jean-Philippe Herbeuval, Gene M Shearer
AIDS Research and Human Retroviruses|August 7, 2007
Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshopClaire A Chougnet, Gene M Shearer
Autoimmunity|December 17, 2009
Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupusCharles S Via, Gene M Shearer
Clinical Immunology (Orlando, Fla.)|November 23, 2006
HIV-1 immunopathogenesis: how good interferon turns badJean-Philippe Herbeuval, Gene M Shearer
Current Infectious Disease Reports|May 23, 2002
The Role of Antigen-presenting Cells in HIV PathogenesisClaire Chougnet, Gene M. Shearer, Alan L. Landay
Neuroscience Letters|May 7, 2008
Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cellsOscar D Cano, Gabriele Neurauter, Dietmar Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2007
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alphaAndrew W Hardy, David R Graham, Gene M Shearer, et al.
Pageof 5